Multiomics analysis reveals aberrant tryptophan-kynurenine metabolism and immunity linked gut microbiota with cognitive impairment in major depressive disorder
- 21 December 2024
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 373, 273-283
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A Cognitive Biotype of Depression Linking Symptoms, Behavior Measures, Neural Circuits, and Differential Treatment OutcomesJAMA Network Open, 2023
- Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axisBiomedicine & Pharmacotherapy, 2023
- In vitro digestion and fermentation combined with microbiomics and metabolomics reveal the mechanism of superfine yak bone powder regulating lipid metabolism by altering human gut microbiotaFood Chemistry, 2023
- Gut microbiota variations in patients diagnosed with major depressive disorder—A systematic reviewBrain and Behavior, 2021
- Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depressionJournal of Affective Disorders, 2020
- Gut microbiota and major depressive disorder: A systematic review and meta-analysisJournal of Affective Disorders, 2020
- Current Perspectives on Gut Microbiome Dysbiosis and DepressionAdvances in Therapy, 2020
- Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorderJournal of Affective Disorders, 2016
- Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studiesJournal of Affective Disorders, 2016
- Elevated Macrophage Migration Inhibitory Factor (MIF) is associated with depressive symptoms, blunted cortisol reactivity to acute stress, and lowered morning cortisolBrain, Behavior, and Immunity, 2010